NCT00291876View on ClinicalTrials.gov

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

January 1, 2004

Primary Completion Date

March 1, 2013

Study Completion Date

March 1, 2013

Conditions
Hepatitis A
Interventions
BIOLOGICAL

Havrix™

2 doses at 12 months interval

Trial Locations (1)

2610

GSK Investigational Site, Wilrijk

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY